Evidence map›Paper›PMID 35036625›Full record

ArticleGlobal health & medicine2021

Algeria's preparedness for Omicron variant and for the fourth wave of COVID-19.

Hani Amir Aouissi

Abstract readNews
In one paragraph

Article in Global health & medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Development of gold nanoparticle-based biosensors for COVID-19 diagnosis.Beni-Suef University journal of basic and applied sciences · 2022
    Review
  15. Review
  16. Article
  17. Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients.Beni-Suef University journal of basic and applied sciences · 2022
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hani Amir AouissiScientific and Technical Research Center on Arid Regions (CRSTRA), Biskra, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world has been confronting a health crisis for two years because of the COVID-19 pandemic. The context of the crisis has the form of the first wave and subsequent waves that varied depending on the country. Undoubtedly, Algeria is one of the countries that have suffered severely from this pandemic. The recent wave has been marked with the huge number of casualties given the poor preparation. The country's preparation issue will be more complicated. In other words, in the context of an expected 4th wave that is characterized with the appearance of the new Omicron variant B.1.1.529. Thus, this news will consider the situation comprehensively and will provide recommendations to minimize the potential damage that will result from the fourth wave, and to attempt to limit the spread of the virus. The updated measures aim at rising the opportunities of improving the health situation in the country in the near future.

Indexed as

AlgeriaCOVID-19global healthOmicronpandemic

Identifiers

PMID35036625
PMCPMC8692091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.